All Research on Pharmaceutical Manufacturers in Europe

Insight

Case Studies
Case Studies

Transition at Teva: Blockbuster drug Copaxone to lose patent protection in 2014

This case study looks at Teva's operations and the market in which it operates, Copaxone, Teva's best-selling drug, and M&A activity Teva has been involved in over recent years, and whether or not it has been successful.

Published By MarketLine
$495
Buy
Case Studies
Case Studies

Orphan Drugs: Rescue from the patent cliff

Big Pharma has gone through some significant changes in recent years: many “blockbuster” drugs are losing their patents. In the orphan drugs market, where companies can charge high premiums for drugs which have little to no competition.

Published By MarketLine
$495
Buy
Case Studies
Case Studies

Pfizer Inc: Re-entry to the OTC healthcare market

Pfizer exited the OTC healthcare market in 2006 with the sale of its Consumer Healthcare division. In 2009, Pfizer re-entered the market. This case study will examine Pfizer's growth, disposal of the OTC division, and the subsequent market re-entry.

Published By MarketLine
$495
Buy

View all Insight >>

Market Data

Databook
Databook

Company Financials: Shire plc

In-depth Company Financials with Key Ratios, and Revenue details by segments and geographies for the last five years download the attached datapack (.xls file)

Published By Datamonitor
$75
Buy

Profiles

Company Profile
Company Profile

STADA Arzneimittel AG

STADA Arzneimittel (STADA or 'the group') is an international company with a focus on the healthcare market, especially the pharmaceutical and in particular the generics market. The group operates in Europe and Asia Pacific. It is headquartered in Bad Vilbel, Germany and employed 9,154 people as on December 31, 2013.

Published By MarketLine
$175
Buy
Company Profile
Company Profile

Recordati S.p.A.

Recordati (or 'the company') is a specialty pharmaceutical company dedicated to partnering, discovering and developing pharmaceutical products. The company has its presence in Europe, Australasia, Africa and America. It is headquartered in Milan, Italy, and employed about 4,000 people as on December 31, 2013.

Published By MarketLine
$175
Buy
Company Profile
Company Profile

ALK-Abello AS

ALK-Abello (or 'the group') is a Denmark-based pharmaceutical group engaged in the development and marketing of allergy treatment products. The group operates in Europe, North America and other parts of the world. It is headquartered in Horsholm, Denmark, and employed 1,763 people as on December 31, 2013.

Published By MarketLine
$175
Buy

View all Profiles >>

No help is available.